ArticleJournal of orthopaedic surgery and research2026
PSMB9 exacerbates chondrocyte injury in osteoarthritis via activation of the NF-κB pathway.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eggshell Membrane Peptides Alleviate IL-1β-Induced Inflammatory Responses and Extracellular Matrix Degradation in Canine Chondrocytes by Inhibiting the NF-κB Signaling Pathway.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOsteoarthritis (OA) is a degenerative disease with incompletely understood mechanisms. The proteasome subunit PSMB9 has been implicated in immune regulation, but its specific role in OA pathogenesis remains unclear. This study aimed to investigate whether PSMB9 mediates IL-1β-induced chondrocyte injury by activating the NF-κB pathway through promoting IκBα degradation, and to explore the regulatory relationship between IL-6 and PSMB9 in OA progression.
methodsDifferentially expressed genes were identified by integrating human and mouse OA datasets. A mouse destabilization of the medial meniscus (DMM) model was established. The function of PSMB9 in OA chondrocytes and its effect on the NF-κB pathway were analyzed using hematoxylin-eosin (H&E) staining, immunohistochemistry, Western blot, CCK-8, Edu, flow cytometry, and immunofluorescence to observe p65 nuclear translocation.
results(1) PSMB9 was significantly upregulated in multiple OA datasets and models; (2) PSMB9 expression increased in the cartilage of OA patients and mice; (3) PSMB9 overexpression exacerbated IL-1β-induced chondrocyte apoptosis, inhibited proliferation, upregulated the expression of the inflammatory factor IL-6 and the matrix-degrading enzyme MMP13, promoted extracellular matrix (ECM) degradation, and decreased COL2A1 expression; (4) PSMB9 activated the NF-κB pathway by promoting IκBα degradation, and inhibition of this pathway alleviated cell injury; (5) silencing IL-6 reduced PSMB9 expression.
conclusionPSMB9 may participate in the activation of the NF-κB pathway and potentially contribute to chondrocyte injury in OA, making it a promising target for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.